Drug Discovery for Nervous System Disorders (R01) | Apply Online

Opportunity Summary:

The Drug Discovery for Nervous System Disorders (R01) opportunity (Funding Opportunity Number PAR-07-048) is a National Institutes of Health (NIH) funding announcement aimed at moving potential treatments for nervous system disorders closer to the clinic by supporting research focused on discovering, developing, and preclinically testing new therapeutic compounds. The central goal is to fund well-justified projects that can identify novel candidate molecules and advance them through the kinds of laboratory and animal-based studies typically required before human testing, with an emphasis on prevention and treatment across a range of neurological and neuropsychiatric conditions. Applications are evaluated through NIH's standard peer review system, then assigned to the appropriate participating NIH Institute for potential funding based on scientific merit and program priorities. There is no dedicated set-aside budget specifically reserved for this announcement, so awards depend on each Institute's available funds and interest in the proposed work.

This announcement uses the R01 research project grant mechanism, which is NIH's main vehicle for supporting mature, hypothesis-driven, multi-year research programs. It is paired with a parallel announcement of the same scientific scope that uses the R21 mechanism (PAR-07-049), which generally supports earlier-stage or more exploratory projects. In practice, that means applicants should choose the R01 route when they have a more developed plan, stronger preliminary foundation, and a clearer path for rigorous preclinical advancement of a compound or compound class, while the companion R21 may be more suitable for higher-risk early discovery efforts.

Funding under this FOA is not guaranteed and is explicitly contingent on two things: the availability of NIH funds at the time of award and the presence of a sufficient number of applications judged to be highly meritorious during peer review. The announcement uses multiple receipt dates rather than a single deadline, meaning proposals can be submitted on recurring NIH due dates as specified in the full announcement. The program was originally posted on November 21, 2006, with an archive date of December 6, 2009, indicating it was active over a defined period and then closed/archived.

Eligibility is broad and includes many types of domestic and international organizations. Eligible applicants include public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (including small businesses as well as other for-profit entities), state and local governments (such as state governments, county governments, city or township governments, and special district governments), public housing authorities/Indian housing authorities, independent school districts, and Native American tribal governments and organizations (including federally recognized tribal governments and other tribal organizations). Importantly, foreign institutions are explicitly eligible to apply, which opens participation to international universities, research institutes, and other qualified entities outside the United States.

The NIH components associated with this opportunity align with several health research areas reflected in the listed CFDA programs: mental health research (93.242), alcohol research (93.273), drug abuse and addiction research (93.279), and aging research (93.866). That mix signals that relevant nervous system disorders may include conditions intersecting with psychiatry, addiction, substance use, neurodegeneration, and age-related neurological disease, among others. The announcement also specifies that cost sharing or matching is not required, which is typical of NIH research grants and reduces the need for applicants to provide non-federal matching funds.

For full requirements, including detailed scientific scope, application instructions, review criteria, and the exact schedule of receipt dates, applicants are directed to the official NIH posting at http://grants.nih.gov/grants/guide/pa-files/PAR-07-048.html. For technical access or linking issues, the NIH Office of Extramural Research (OER) webmaster is provided as a point of contact.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R01)

Previous opportunity: Research on Chronic Insomnia Disorder (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 07 048

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 07 048) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 07 048", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.